General information

Announcements(21)

Program

Sessions

Search presentations

Download PDF for print

Timetable

Tue. Nov 26, 2024

Wed. Nov 27, 2024

Thu. Nov 28, 2024

Fri. Nov 29, 2024

web_header_st_en.png

Announcements

Profile management

Bookmark

Program Type

Live Streaming Available

Late-breaking Abstract

ポスターカテゴリ

Change account information such as the email address and password on the account setting screen common to Confit.

Log in to make the most of the service, such as bookmark registration.<br><span style="color: #e03e2d;">※To download your name badge or registration fee receipt, please click <a href="https://mbsj.confit.atlas.jp/en">here</a>.</span>

Login required to view

Password required to view

Presentation Information

Session Details

To browse or post comments, you must log in.

You cannot post comments as it is outside the comment posting period.

This comment has been deleted. You cannot reply to this comment.

Evaluation and engineering of monoclonal antibodies using reconstituted cell-free protein synthesis

In the field of academic drug discovery, the intellectual property on the academic side isn't just limited to the drugs themselves. Companies see value in unique drug targets, know-how, and Proof Of Concept (POC). However, academia doesn't seem to place much emphasis on these intellectual properties. They've somewhat reduced patents to a mere 'pre-paper formality'. This approach hinders the growth of open innovation, and right now, academic drug discovery is in need of a significant shift. In this symposium, we aim to delve deeply into the practical aspects of drug discovery without the barriers between companies and universities. We've invited promising speakers to foster the advancement of academic drug discovery, striving to establish a foundation for mutual support through the latest technologies and research.<br>

【J】Academic Drug Development Conference 2024

The 47th Annual Meeting of the Molecular Biology Society of Japan

Presentation Information

[1PS-15-01]Evaluation and engineering of monoclonal antibodies using reconstituted cell-free protein synthesis

Password required to view

Comment